Form 8-K - Current report:
SEC Accession No. 0001104659-24-072272
Filing Date
2024-06-17
Accepted
2024-06-17 16:15:31
Documents
13
Period of Report
2024-06-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2417381d1_8k.htm   iXBRL 8-K 35734
  Complete submission text file 0001104659-24-072272.txt   207959

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA supn-20240614.xsd EX-101.SCH 3015
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE supn-20240614_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE supn-20240614_pre.xml EX-101.PRE 22359
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2417381d1_8k_htm.xml XML 3577
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35518 | Film No.: 241048404
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)